130 related articles for article (PubMed ID: 37019145)
1. Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
Aktekin EH; Gezer HÖ; Yazıcı N; Erol İ; Erbay A; Sarıalioğlu F
Neuropediatrics; 2024 Feb; 55(1):57-62. PubMed ID: 37019145
[TBL] [Abstract][Full Text] [Related]
2. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
3. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and prognostic analysis of opsoclonus-myoclonus-ataxia syndrome in children].
Zhou J; Zhuo XW; Jin M; Duan C; Zhang WH; Ren CH; Gong S; Tian XJ; Ding CH; Ren XT; Li JW
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):256-261. PubMed ID: 38378288
[No Abstract] [Full Text] [Related]
5. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
Patel A; Fischer C; Lin YC; Basu EM; Kushner BH; De Braganca K; Khakoo Y
Pediatr Blood Cancer; 2020 Aug; 67(8):e28319. PubMed ID: 32543116
[TBL] [Abstract][Full Text] [Related]
6. A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome.
Altunsoy A; Kemirtlek N; Araz H; Dirik EB; Akıncı E
J Infect Dev Ctries; 2024 Feb; 18(2):188-194. PubMed ID: 38484346
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-limited Setting.
Anand S; Agarwala S; Jain V; Bakhshi S; Dhua A; Gulati S; Seth R; Srinivas M; Jana M; Kandasamy D; Bhatnagar V
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e924-e929. PubMed ID: 33769388
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.
Rossor T; Yeh EA; Khakoo Y; Angelini P; Hemingway C; Irani SR; Schleiermacher G; Santosh P; Lotze T; Dale RC; Deiva K; Hero B; Klein A; de Alarcon P; Gorman MP; Mitchell WG; Lim M;
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260471
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
[TBL] [Abstract][Full Text] [Related]
10. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma-associated Opsoclonous Myoclonous Ataxia Syndrome: Profile and Outcome Report on 15 Egyptian Patients.
Elzomor H; El Menawi S; Elawady H; Elkinaai N; Elshafie M; Refaat A; Ghareeb H; Fawzy M
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e194-e199. PubMed ID: 35462382
[TBL] [Abstract][Full Text] [Related]
12. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
13. Opsoclonus-myoclonus-ataxia syndrome in children.
Bhatia P; Heim J; Cornejo P; Kane L; Santiago J; Kruer MC
J Neurol; 2022 Feb; 269(2):750-757. PubMed ID: 33779841
[TBL] [Abstract][Full Text] [Related]
14. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
de Alarcon PA; Matthay KK; London WB; Naranjo A; Tenney SC; Panzer JA; Hogarty MD; Park JR; Maris JM; Cohn SL
Lancet Child Adolesc Health; 2018 Jan; 2(1):25-34. PubMed ID: 29376112
[TBL] [Abstract][Full Text] [Related]
16. Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.
Prabaharan H; Chandrasekaran S; Shetty N; Nayak K P
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417946
[TBL] [Abstract][Full Text] [Related]
17. Surgical considerations for neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: a series of 14 patients from a single institution.
Johnston WR; Hwang R; Mattei P
Pediatr Surg Int; 2022 Feb; 38(2):249-255. PubMed ID: 34549330
[TBL] [Abstract][Full Text] [Related]
18. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
[TBL] [Abstract][Full Text] [Related]
19. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
Russo C; Cohn SL; Petruzzi MJ; de Alarcon PA
Med Pediatr Oncol; 1997 Apr; 28(4):284-8. PubMed ID: 9078325
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments.
Bacchus MK; Anderson DS; Berko ER; States LJ; Bagatell R; Hopkins SE; Batra V
J Pediatr Hematol Oncol; 2023 Apr; 45(3):152-154. PubMed ID: 36897628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]